| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $183.0M | +948.6% |
| R&D Expense | $53.4M | +6.1% |
| SG&A Expense | $237.3M | +118.3% |
| Operating Income | -$120.6M | +15.8% |
| Interest Expense | $7.8M | +134.6% |
| Pre-tax Income | -$115.6M | +15.0% |
| Income Tax | $0 | — |
| Net Income | -$115.6M | +15.0% |
| EPS (Basic) | -$3.07 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $94.8M | -57.8% |
| Short-term Investments | $196.6M | +7778.0% |
| Accounts Receivable | $46.8M | +181.3% |
| Inventory | $2.6M | -15.7% |
| Current Assets | $356.7M | +39.3% |
| Total Assets | $377.0M | +42.0% |
| Current Liabilities | $80.6M | +118.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$83.0M | +29.3% |
| Capital Expenditures | $1.6M | +4.3% |
| Investing Cash Flow | -$199.2M | -241.7% |
| Financing Cash Flow | $154.7M | +18.8% |
| Free Cash Flow | -$84.6M | +28.9% |
| +33.5% |
| EPS (Diluted) | -$3.07 | +33.5% |
| Long-term Debt |
| $71.8M |
| +140.9% |
| Total Liabilities | $152.5M | +122.6% |
| Stockholders' Equity | $224.5M | +14.0% |